WHO ICTRP trial
To evaluate the efficacy and safety of TAP-1503 cream in the treatment of atopic…
ChiCTR2400083192 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400083192 |
|---|---|
| Public title | To evaluate the efficacy and safety of TAP-1503 cream in the treatment of atopic dermatitis |
| Scientific title | A multicenter, randomized, double-blind, placebo-controlled clinical trial evaluating the efficacy and safety of TAP-1503 cream in patients 2 years and older with atopic dermatitis |
| Primary sponsor | Peking University People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 3 |
| Countries | China |
| Conditions | Atopic Dermatitis |
| Interventions | Experimental group:TAP-1503 Cream;Control group:Placebo |
| Registration date | Apr 17, 2024 |
| Target size | Experimental group:166;Control group:83 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: